Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 1
1995 2
1996 2
1997 2
1998 2
1999 3
2000 2
2001 2
2002 3
2003 2
2004 1
2005 4
2006 3
2007 1
2008 4
2009 6
2010 7
2011 3
2012 11
2013 8
2014 8
2015 5
2016 5
2017 6
2018 3
2019 6
2020 2
2021 8
2022 10
2023 2
2024 8
2025 10
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Results by year

Filters applied: . Clear all
Page 1
Challenges and Recommendations for Integrating Circadian Medicine in Critical Care: A Roadmap.
Hiemstra FW, González LB, Engelhardt LJ, Hancke L, Pilz LK, Adler AI, Dashti HS, Drouot X, Kitchen GB, Knauert MP, Kramer A, Lipton JO, Luetz A, Maas MB, Pajor NM, Parthasarathy S, Spies C, van Westerloo DJ, Felten M, Klerman EB, Ray DW, Ruben MD, Roenneberg T, Kervezee L. Hiemstra FW, et al. Among authors: adler ai. Chest. 2026 Apr;169(4):977-990. doi: 10.1016/j.chest.2025.12.010. Epub 2025 Dec 20. Chest. 2026. PMID: 41429288 Free PMC article. Review.
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Gillessen S, Murphy L, James ND, Sachdeva A, El-Taji O, Abdel-Aty H, Adler AI, Amos C, Attard G, Varughese M, Gale J, Brown S, Srihari N, Birtle AJ, Brown M, Chan K, Chowdhury S, Cross W, Dearnaley DP, Din O, Dutey-Magni P, Gilbert DC, Gilson C, Gray S, Grist E, Hofmann U, Hudson AM, Jain Y, Jeyasangar G, Jones R, Kayani M, Langley RE, Malik Z, Mason MD, Matheson D, McAlpine C, Macnair A, Millman R, Murphy C, Padden-Modi M, Parikh O, Parker C, Rush H, Russell M, Srinivasan R, Sundar S, Tanguay JS, Turco F, Williams P, Sydes MR, Parmar MKB, Brown LC, Clarke NW; STAMPEDE investigators. Gillessen S, et al. Among authors: adler ai. Lancet Oncol. 2025 Aug;26(8):1018-1030. doi: 10.1016/S1470-2045(25)00231-1. Epub 2025 Jul 7. Lancet Oncol. 2025. PMID: 40639383 Free PMC article. Clinical Trial.
Comparative effectiveness of alternative second-line oral glucose-lowering therapies for type 2 diabetes: a precision medicine approach applied to routine data.
O'Neill S, Bidulka P, Lugo-Palacios DG, Carroll O, Leiva-Escobar I, Silverwood R, Briggs A, Adler AI, Khunti K, Grieve R. O'Neill S, et al. Among authors: adler ai. Diabetologia. 2025 Sep;68(9):1908-1923. doi: 10.1007/s00125-025-06447-x. Epub 2025 May 31. Diabetologia. 2025. PMID: 40450157 Free PMC article.
Long-term outcomes following alternative second-line oral glucose-lowering treatments: Results from the real-world progression in type 2 diabetes mellitus United Kingdom (RAPIDS-UK) model.
Carroll OU, Bidulka P, Basu A, Adler AI, O'Neill S, Briggs AH, Lugo-Palacios DG, Khunti K, Grieve R. Carroll OU, et al. Among authors: adler ai. Diabetes Obes Metab. 2025 Aug;27(8):4181-4191. doi: 10.1111/dom.16447. Epub 2025 May 21. Diabetes Obes Metab. 2025. PMID: 40400097 Free PMC article.
130 results